Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine.

Source:http://linkedlifedata.com/resource/pubmed/id/8623479

Download in:

View as

General Info

PMID
8623479